Tag: Parkinson’s disease October 5, 2021 $35 million to support study of sleep disorder linked to neurodegenerationInternational team seeks hidden signs of brain damage in REM behavior disorder.News Release July 8, 2021 New Alzheimer’s treatment targets identifiedStudy points to FDA-approved drugs that have potential to slow or reverse brain damage.News Release October 6, 2020 Brain inflammation in Parkinson’s disease focus of $3.2 million grantStudy probes inflammation’s role in spreading brain damage; may have implications for MS, Alzheimer’s, other neurodegenerative diseases.News Release June 4, 2020 $3.7 million aimed at studying effect of manganese exposure on cognitive skillsStudy of welders could shine light on early stages of Parkinson’s disease.News Release February 5, 2020 Gene ID’d as potential therapeutic target for dementia in Parkinson’sTargeting gene linked to Alzheimer’s may reduce dementia risk in Parkinson’s.News Release December 10, 2019 Why doesn’t deep-brain stimulation work for everyone?Personalized brain maps could improve treatment for Parkinson's disease, other neurological conditions.News Release March 26, 2019 Rineys give $15 million to develop, test therapies for neurodegenerative diseasesGift will fund Alzheimer’s, Parkinson’s research.News Release May 31, 2018 Drugs that suppress immune system may protect against Parkinson’sPeople who take immunosuppressants less likely to develop the disease.News Release October 13, 2017 $3.7 million to help research neurological disorders linked to manganeseFocus in South Africa, where most manganese found.News Release September 14, 2017 Medical history can point to earlier Parkinson’s disease diagnosisAlgorithm could alert doctors to evaluate for the disease.News Release Posts navigation
